Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Oct 2018. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 110897501000001114 | Cetraxal Plus 3mg/ml + 0.25mg/ml ear drops 0.25ml unit dose (Aspire Pharma Ltd) 15 unit dose 3 x 5 x 0.25ml unit doses (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 110897601000001113 | Cetraxal Plus 3mg/ml + 0.25mg/ml ear drops 0.25ml unit dose (Aspire Pharma Ltd) 15 unit dose 3 x 5 x 0.25ml unit doses | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Cetraxal Plus 3mg/ml + 0.25mg/ml ear drops 0.25ml unit dose (Aspire Pharma Ltd) 15 unit dose 3 x 5 x 0.25ml unit doses | Has excipient | Excipient not declared | true | Inferred relationship | Existential restriction modifier | ||
| Cetraxal Plus 3mg/ml + 0.25mg/ml ear drops 0.25ml unit dose (Aspire Pharma Ltd) 15 unit dose 3 x 5 x 0.25ml unit doses | Has NHS dm+d (dictionary of medicines and devices) controlled drug category | Controlled drug category No Controlled Drug Status | true | Inferred relationship | Existential restriction modifier | ||
| Cetraxal Plus 3mg/ml + 0.25mg/ml ear drops 0.25ml unit dose (Aspire Pharma Ltd) 15 unit dose 3 x 5 x 0.25ml unit doses | Has NHS dm+d (dictionary of medicines and devices) freeness indicator | Preservative free | true | Inferred relationship | Existential restriction modifier | ||
| Cetraxal Plus 3mg/ml + 0.25mg/ml ear drops 0.25ml unit dose (Aspire Pharma Ltd) 15 unit dose 3 x 5 x 0.25ml unit doses | Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator | NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none | true | Inferred relationship | Existential restriction modifier | ||
| Cetraxal Plus 3mg/ml + 0.25mg/ml ear drops 0.25ml unit dose (Aspire Pharma Ltd) 15 unit dose 3 x 5 x 0.25ml unit doses | Is a | Ciprofloxacin 3mg/ml / Fluocinolone acetonide 0.25mg/ml ear drops 0.25ml unit dose preservative free 15 unit dose | true | Inferred relationship | Existential restriction modifier | ||
| Cetraxal Plus 3mg/ml + 0.25mg/ml ear drops 0.25ml unit dose (Aspire Pharma Ltd) 15 unit dose 3 x 5 x 0.25ml unit doses | Has AMP | Cetraxal Plus 3mg/ml + 0.25mg/ml ear drops 0.25ml unit dose (Aspire Pharma Ltd) | true | Inferred relationship | Existential restriction modifier | ||
| Cetraxal Plus 3mg/ml + 0.25mg/ml ear drops 0.25ml unit dose (Aspire Pharma Ltd) 15 unit dose 3 x 5 x 0.25ml unit doses | Has excipient | Polysorbate | false | Inferred relationship | Existential restriction modifier | ||
| Cetraxal Plus 3mg/ml + 0.25mg/ml ear drops 0.25ml unit dose (Aspire Pharma Ltd) 15 unit dose 3 x 5 x 0.25ml unit doses | VMP prescribing status (attribute) | VMP valid as a prescribable product | true | Inferred relationship | Existential restriction modifier | ||
| Cetraxal Plus 3mg/ml + 0.25mg/ml ear drops 0.25ml unit dose (Aspire Pharma Ltd) 15 unit dose 3 x 5 x 0.25ml unit doses | VMP non-availability indicator | Available | true | Inferred relationship | Existential restriction modifier | ||
| Cetraxal Plus 3mg/ml + 0.25mg/ml ear drops 0.25ml unit dose (Aspire Pharma Ltd) 15 unit dose 3 x 5 x 0.25ml unit doses | Has specific active ingredient | Ciprofloxacin hydrochloride | true | Inferred relationship | Existential restriction modifier | ||
| Cetraxal Plus 3mg/ml + 0.25mg/ml ear drops 0.25ml unit dose (Aspire Pharma Ltd) 15 unit dose 3 x 5 x 0.25ml unit doses | Has specific active ingredient | Fluocinolone acetonide | true | Inferred relationship | Existential restriction modifier | ||
| Cetraxal Plus 3mg/ml + 0.25mg/ml ear drops 0.25ml unit dose (Aspire Pharma Ltd) 15 unit dose 3 x 5 x 0.25ml unit doses | Has dispensed dose form | Conventional release ear drops | true | Inferred relationship | Existential restriction modifier | ||
| Cetraxal Plus 3mg/ml + 0.25mg/ml ear drops 0.25ml unit dose (Aspire Pharma Ltd) 15 unit dose 3 x 5 x 0.25ml unit doses | Has NHS dm+d (dictionary of medicines and devices) basis of strength substance | Ciprofloxacin | true | Inferred relationship | Existential restriction modifier | ||
| Cetraxal Plus 3mg/ml + 0.25mg/ml ear drops 0.25ml unit dose (Aspire Pharma Ltd) 15 unit dose 3 x 5 x 0.25ml unit doses | Has unit of administration | drop | false | Inferred relationship | Existential restriction modifier | ||
| Cetraxal Plus 3mg/ml + 0.25mg/ml ear drops 0.25ml unit dose (Aspire Pharma Ltd) 15 unit dose 3 x 5 x 0.25ml unit doses | Legal category | Prescription only medicine - legal category (qualifier value) | true | Inferred relationship | Existential restriction modifier | ||
| Cetraxal Plus 3mg/ml + 0.25mg/ml ear drops 0.25ml unit dose (Aspire Pharma Ltd) 15 unit dose 3 x 5 x 0.25ml unit doses | Discontinued indicator | Never discontinued | true | Inferred relationship | Existential restriction modifier | ||
| Cetraxal Plus 3mg/ml + 0.25mg/ml ear drops 0.25ml unit dose (Aspire Pharma Ltd) 15 unit dose 3 x 5 x 0.25ml unit doses | Is a | Actual medicinal product pack | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR